Hypoxia imaging with [F-18] FMISO-PET in head and neck cancer: potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance.
暂无分享,去创建一个
Wade P. Smith | Lanell Peterson | M. Phillips | K. Krohn | J. Rajendran | K. Hendrickson | L. Peterson | Mark Phillips | Joseph Rajendran | Kenneth Krohn | Kristi Hendrickson | Wade Smith | W. Smith
[1] Joseph O Deasy,et al. Radiotherapy dose-volume effects on salivary gland function. , 2010, International journal of radiation oncology, biology, physics.
[2] T. Schultheiss,et al. Radiation dose-volume effects in the spinal cord. , 2010, International journal of radiation oncology, biology, physics.
[3] Sadek Nehmeh,et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[4] Daniela Thorwarth,et al. Hypoxia dose painting by numbers: a planning study. , 2007, International journal of radiation oncology, biology, physics.
[5] Nancy Lee,et al. Intensity‐modulated radiation therapy in head and neck cancers: An update , 2007, Head & neck.
[6] D. Olsen,et al. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study , 2007, Physics in medicine and biology.
[7] M. Phillips,et al. 2614 : Parametric Images Derived From Kinetic Modeling of Dynamic [F-18] FMISO PET - Evaluating the Feasibility of IMRT Based Dose Escalation to Hypoxic Sub-Volumes , 2006 .
[8] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[9] Brian O'Sullivan,et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis , 2006, The Lancet.
[10] David J. Carlson,et al. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parametersa). , 2006, Medical physics.
[11] X. Li,et al. Dose escalation to combat hypoxia in prostate cancer: a radiobiological study on clinical data. , 2006, The British journal of radiology.
[12] D. Mankoff,et al. Hypoxia imaging-directed radiation treatment planning , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[13] Performance evaluation of an integrated PET/CT scanner: Discovery STE , 2006 .
[14] R. Fisher,et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Vladimir A Semenenko,et al. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. , 2006, Medical physics.
[16] K. Krohn,et al. A new synthesis of the labeling precursor for [18F]- fluoromisonidazole , 2005 .
[17] Kenneth A Krohn,et al. Imaging hypoxia and angiogenesis in tumors. , 2005, Radiologic clinics of North America.
[18] K. Ang,et al. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma. , 2004, Seminars in radiation oncology.
[19] Anders Brahme,et al. Recent advances in light ion radiation therapy. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[20] F. O’Sullivan,et al. Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [F]Fluoromisonidazole and [F]Fluorodeoxyglucose Positron Emission Tomography Imaging , 2004 .
[21] Alessandra Bolsi,et al. Comparative dosimetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Cai Grau,et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial , 2003, The Lancet.
[23] C. Koch,et al. Prognostic significance of tumor oxygenation in humans. , 2003, Cancer letters.
[24] J. Eary,et al. [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[25] Richard A Popple,et al. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. , 2002, International journal of radiation oncology, biology, physics.
[26] M. Muzi,et al. Analyzing the results of 18FMISO PET hypoxia imaging What is the best way to quantify hypoxia , 2002 .
[27] S Mutic,et al. A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. , 2001, International journal of radiation oncology, biology, physics.
[28] J. Brown,et al. Therapeutic targets in radiotherapy. , 2001, International journal of radiation oncology, biology, physics.
[29] H. Withers,et al. Transmutability of dose and time. Commentary on the first report of RTOG 90003 (K. K. FU et al.) , 2000, International journal of radiation oncology, biology, physics.
[30] D A Low,et al. Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.
[31] A. Garden,et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. , 2000, International journal of radiation oncology, biology, physics.
[32] D A Bloch,et al. Tissue oxygen distribution in head and neck cancer patients , 1999, Head & neck.
[33] D. Low,et al. Quality assurance of serial tomotherapy for head and neck patient treatments. , 1998, International journal of radiation oncology, biology, physics.
[34] Paul Kinahan,et al. Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.
[35] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[36] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[37] Christopher U. Jones,et al. Local control of carcinoma of the tonsil by radiation therapy: an analysis of patterns of fractionation in nine institutions. , 1995, International journal of radiation oncology, biology, physics.
[38] Thomas K. Lewellen,et al. Investigation of the count rate performance of General Electric Advance positron emission tomograph , 1995 .
[39] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[40] C. Stearns,et al. Investigation of the count rate performance of the General Electric Advance positron emission tomograph , 1994, Proceedings of 1994 IEEE Nuclear Science Symposium - NSS'94.
[41] T G Turkington,et al. Performance characteristics of a whole-body PET scanner. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[42] S Webb,et al. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. , 1993, Physics in medicine and biology.
[43] P Vaupel,et al. Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix. , 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[45] C. Burman,et al. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. , 1989, International journal of radiation oncology, biology, physics.
[46] J. M. Taylor,et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation. , 1989, International journal of radiation oncology, biology, physics.
[47] Michael V. Green,et al. Post-injection transmission attenuation measurements for PET , 1988 .
[48] A B Wolbarst,et al. Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms. , 1987, International journal of radiation oncology, biology, physics.
[49] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[50] J. Lyman. Complication probability as assessed from dose-volume histograms. , 1985, Radiation research. Supplement.